Globus Medical/GMED

$63.64

-0.48%
-
1D1W1MYTD1YMAX

About Globus Medical

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

Ticker

GMED

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

David Paul

Employees

5,000

Headquarters

Audubon, United States

Globus Medical Metrics

BasicAdvanced
$8.7B
Market cap
102.11
P/E ratio
$0.63
EPS
1.15
Beta
-
Dividend rate
$8.7B
1.14788
$65.74
$43.39
1.2M
2.325
1.287
0.008
10.829
54.855
1.88%
2.28%
2.17%
102.106
4.591
2.222
5.505
57.442
77.59%
-68.04%
25.74%
1.9%

What the Analysts think about Globus Medical

Analyst Ratings

Majority rating from 16 analysts.
Hold

Price Targets

Average projection from 13 analysts.
7.34% upside
High $85.00
Low $55.00
$63.64
Current price
$68.31
Average price target

Globus Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1.17% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$607M
-1.61%
Net income
-$7.1M
-147.33%
Profit margin
-1.17%
-148.15%

Globus Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 26.86%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.63
$0.57
$0.60
$0.72
-
Expected
$0.59
$0.57
$0.61
$0.57
$0.68
Surprise
6.17%
-0.29%
-1.64%
26.86%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Globus Medical stock?

Globus Medical (GMED) has a market cap of $8.7B as of May 18, 2024.

What is the P/E ratio for Globus Medical stock?

The price to earnings (P/E) ratio for Globus Medical (GMED) stock is 102.11 as of May 18, 2024.

Does Globus Medical stock pay dividends?

No, Globus Medical (GMED) stock does not pay dividends to its shareholders as of May 18, 2024.

When is the next Globus Medical dividend payment date?

Globus Medical (GMED) stock does not pay dividends to its shareholders.

What is the beta indicator for Globus Medical?

Globus Medical (GMED) has a beta rating of 1.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Globus Medical stock price target?

The target price for Globus Medical (GMED) stock is $68.31, which is 6.07% above the current price of $64.4. This is an average based on projections from 13 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Globus Medical stock

Buy or sell Globus Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing